InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,040.02
(
-0.32%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Sikmarson

Send PM Follow Ignore
Followers 2
Posts 79
Boards Moderated 0
Alias Born 06/23/2014

Sikmarson

Re: None

Thursday, 02/26/2015 10:40:48 AM

Thursday, February 26, 2015 10:40:48 AM

Post# of 80490
More interesting abstracts to present on AACR Annual Meeting 2015
April 18 - 22, 2015

Presentation Title: Discovery of AP26113, a potent, orally active inhibitor of anaplastic lymphoma kinase and clinically relevant mutants

Presentation Title: The potent ALK inhibitor AP26113 can overcome mechanisms of resistance to first- and second-generation ALK TKIs in preclinical models

Presentation Title: Ponatinib demonstrates antitumor activity in RET- and FGFR-driven patient-derived xenografts



AACR abstract search

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up